Multiregion Biopsies and Corresponding Neurosphere Cultures Reveal Spatial Divergence in Glioblastoma
Intratumor heterogeneity (ITH) is one of the main reasons for the lack of effective targeted therapies for glioblastoma multiforme (GBM). Imaging-guided surgical navigation allows for tumor-wide sampling to account for variation between distant regions of the tumor, but typical drug screening is performed on cell lines derived from a single biopsy and does not account for GBM heterogeneity. We aimed to characterize ITH in spatially distinct tumor biopsies and test how these location-related phenotypes can be propagated in vitro.
We obtained human glioblastoma tumor biopsies from distinct regions of the tumor from 9 cases. For cases OS1, OS3 and OS7, we performed cell sorting based on 5-ALA, which accumulates in GBM cells, allowing for separation of tumor cells and cells of the microenvironment. Single-cell sequencing data for OS1 and bulk sequencing for the other fractions was performed.
From the remaining 6 GBM cases, we collected 40 biopsies in total, and performed RNA and exome sequencing. Neurosphere cultures were successfully derived from 30 of these biopsies, expanded and used for bulk RNA sequencing. Proliferation, 5-ALA accumulation and drug sensitivity was also measured.
We also found that the cellular composition of the original tumor sample, predicted based on bulk transcriptomic data, can be linked to drug response outcomes derived from respective neurosphere line. Thus, while GBM neurospheres represent a valid tumor model, their spatial origin and heterogeneity need to be accounted for to enable reconstruction of GBM ecosystem in targeted therapeutic screening efforts.
- Type: Case Set
- Archive: The database of Genotypes and Phenotypes (dbGaP)
